StockNews.AI
DMAC
StockNews.AI
161 days

DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025

1. DiaMedica will release FY2024 financial results on March 17. 2. A conference call is scheduled for March 18 to discuss results.

2m saved
Insight
Article

FAQ

Why Bullish?

Earnings announcements often lead to stock price movements. Positive performance can enhance investor confidence and increase stock value.

How important is it?

The earnings announcement is pivotal for investor expectations. Positive results may improve DMAC's financial outlook, influencing market perception significantly.

Why Short Term?

Market reactions to earnings are typically immediate, affecting prices shortly after announcements. For instance, DMAC could experience volatility upon the March earnings call.

Related Companies

AMGNMRNABMY
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today that its full-year 2024 financial results will be released after the markets close on Monday, March 17th. DiaMedica will host a live conference call on Tuesday, March 18th at 7:00 AM Central Time to provide a business update and discuss financial results. Conference Call details: Date: Tuesday, M.

Related News